USE OF CA-19-9 IN THE EARLY DETECTION OF RECURRENCES IN COLORECTAL-CANCER - COMPARISON WITH CEA

被引：45

作者：

FILELLA, X

MOLINA, R

PIQUE, JM

GARCIAVALDECASAS, JC

GRAU, JJ

NOVELL, F

ASTUDILLO, E

DELACY, A

DANIELS, M

BALLESTA, AM

机构：

[1] HOSP CLIN BARCELONA,DEPT GASTROENTEROL,BARCELONA,SPAIN

[2] HOSP CLIN BARCELONA,DEPT SURG,BARCELONA,SPAIN

[3] HOSP CLIN BARCELONA,DEPT ONCOL,BARCELONA,SPAIN

来源：

TUMOR BIOLOGY | 1994年 / 15卷 / 01期

关键词：

CA; 19-9; CEA; CANCER-ASSOCIATED ANTIGENS; COLORECTAL CANCER; FOLLOW-UP;

D O I：

10.1159/000217867

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The serum levels of CA 19-9 were determined in the follow-up of 370 patients with colorectal cancer and compared with CEA. An increase in CA 19-9 preceded clinical diagnosis of recurrence in 25% of 72 patients. The mean time between the rise in CA 19-9 and clinical diagnosis of relapse was 3.7 months (median 3). Sensitivity of CA 19-9 in the early diagnosis of recurrence was much lower than that obtained for CEA (75%). Only 1 patient had elevated CA 19-9 levels and normal CEA.

引用

页码：1 / 6

页数：6

共 27 条

[1]

Barone D, 1988, Int J Biol Markers, V3, P95

[2]

BENHAMOU PY, 1991, DIABETES METAB, V17, P39

[3]

BRUHN HD, 1985, TUMOUR MARKER ANTIGE, P94

[4] TUMOR-MARKERS IN CHRONIC-RENAL-FAILURE AND HEMODIALYSIS-PATIENTS [J].

CASES, A ;

FILELLA, X ;

MOLINA, R ;

BALLESTA, AM ;

LOPEZPEDRET, J ;

REVERT, L .

NEPHRON, 1991, 57 (02) :183-186

[5]

DELVILLANO BC, 1983, CLIN CHEM, V29, P549

[6] CEA LEVELS IN PATIENTS WITH COLORECTAL POLYPS [J].

DOOS, WG ;

WOLFF, WI ;

SHINYA, H ;

DECHABON, A ;

STENGER, RJ ;

GOTTLIEB, LS ;

ZAMCHECK, N .

CANCER, 1975, 36 (06) :1996-2003

[7] PROGNOSTIC VALUE OF CA-19.9 LEVELS IN COLORECTAL-CANCER [J].

FILELLA, X ;

MOLINA, R ;

GRAU, JJ ;

PIQUE, JM ;

GARCIAVALDECASAS, JC ;

ASTUDILLO, E ;

BIETE, A ;

BORDAS, JM ;

NOVELL, A ;

CAMPO, E ;

BALLESTA, AM .

ANNALS OF SURGERY, 1992, 216 (01) :55-59

[8]

GUPTA MK, 1985, CANCER, V56, P277, DOI 10.1002/1097-0142(19850715)56:2<277::AID-CNCR2820560213>3.0.CO

[9]

2-M

[10]

KELLY CJ, 1992, CANCER-AM CANCER SOC, V70, P1397, DOI 10.1002/1097-0142(19920901)70:3+<1397::AID-CNCR2820701531>3.0.CO

← 1 2 3 →